Patients with leptomeningeal metastasis (LM) have historically had few treatment options. Now, researchers from The University of Texas MD Anderson Cancer Center have found a combination of targeted ...

"Now, the person making the call is somebody somewhere who works for (the insurance company). It's not my physician, who's an expert." | Opinion ...

Significantly more patients had no chemotherapy-induced thrombocytopenia-induced modification of chemo dose with romiplostim vs placebo.

A £1 million research project led by the University of Sheffield is developing a new generation of “smart” drug delivery ...

Pharmacosmos initiates phase III clinical trial of trilaciclib in limited-stage small cell lung cancer MORRISTOWN, NJ, ...

Despite decades of advancements in surgical techniques, chemotherapy, and radiotherapy, the clinical outlook for patients diagnosed with primary brain tumors remains sobering. Whi ...

Baby Lucia is tiny but mighty, says her mother Florita Sanchez of Pasco. At four months old she’s just finished her third round of chemotherapy at Seattle Children’s Hospital for a rare childhood ...

The finding suggests other chemo drugs, too, may be making cancer cells cause a surprising immune-system reaction.

A DR5-mediated apoptotic strategy combined with irinotecan/temozolomide achieved a 64.5% ORR and 87.1% DCR in ...

But the injectable drug romiplostim (Nplate) can effectively prevent chemo from causing thrombocytopenia, by boosting bone marrow cells’ ability to withstand the cancer treatment, researchers reported ...

Epigenetic therapies are offering a more targeted way to treat some lymphomas by changing how genes are turned on or off ...

Studies published in 2025 reveal personalized treatments and a drug combination that helped metastatic breast cancer patients live longer without disease progression.